Share >  
Share
Share on Tumblr

Novo Nordisk

News »

   latest by relevance
Biocon shrs rise on insulin products deal with Mylan
Feb 14, 2013 at 10:18 | Source: Moneycontrol.com
Biocon shares rose 2 percent in morning trade on Thursday after the biotechnology company said it has enhanced its partnership with pharma major Mylan through a strategic collaboration for insulin products.
Sun Pharma wins US case for Prandin copy; FDA nod now key
Apr 18, 2012 at 14:20 | Source: Moneycontrol.com
Shares of pharma major Sun Pharmaceutical Industries rose over 2.5% on Wednesday, after US Supreme Court gave a verdict in favour of its arm Caraco Pharmaceutical Laboratories in the ongoing battle with Novo Nordisk for a generic version of diabetic drug Prandin.
Experts debate: Why Indians are so susceptible to diabetes
Apr 16, 2012 at 18:54 | Source: CNBC-TV18
Novo Nordisk, in association with CNBC-TV18, presents "Improving Control of Diabetes Pandemic in India". In this discussion, experts address the challenges and management of diabetes in India.
Novo Nordisk bets on blockbuster drug to retain top spot
Mar 20, 2012 at 21:43 | Source: CNBC-TV18
Multi-national drug companies are queuing up to enter India and tap its growing anti-diabetes drug market. But Novo Nordisk, which has been in the Indian insulin market for 75 years, is not worried, reports CNBC-TV18's Archana Shukla.
Pfizer ending Insulin deal a big blow for Biocon; shrs tank
Mar 13, 2012 at 10:30 | Source: Moneycontrol.com
Pfizer - Biocon alliance has called off due to individual priorities and in Shares of Biocon fell more than 8% on Tuesday morning after US pharma major Pfizer scrapped a deal to sell insulin products made by the Bangalore-based biotechnology company.
Biocon-Pfizer insulin deal might collapse soon: PharmAsia
Mar 12, 2012 at 21:59 | Source: CNBC-TV18
The deal between Biocon and Pfizer to market a range of insulin products may be in crisis. Vikas Dandekar, the India Bureau Chief of PharmAsia News who broke this story tells CNBC-TV18 that while sources are saying talks are on to salvage the deal, it is most likely to be called off.

Videos »
Experts debate: Why Indians are so susceptible to diabetes
Novo Nordisk bets on blockbuster drug to retain top spot
Biocon-Pfizer insulin deal might collapse soon: PharmAsia
Oral insulin to remain a pin prick for pharma cos' research
30m people to suffer from diabetes in 20 yrs: Novo Nordisk
more »

Photos »

  /  
Interact & exchange stock tips & market info »

richard_ste
ep

Gold Member

2 Followers

Biocon  

with BMS, this will take another two years minimum, assuming the rese...

2.08 PM Feb 11th

Web Messenger

Platinum Member

166941 Followers

News Now  

Source:Business Week - European stocks rose after a report said Spain ...

2.07 PM Sep 22nd 2012

Web Messenger

Platinum Member

166941 Followers

News Now  

Source:Market Watch - MADRID (MarketWatch) — European stock markets...

11.13 AM Aug 10th 2012

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window